| Name | Title | Contact Details |
|---|
Le groupe international Ondura est spécialisé dans les solutions détanchéité pour les bâtiments et regroupe des entreprises leaders dans leurs domaines : Onduline (toiture légère pour les toits en pente), CB (écrans de protection pour façades et de sous-toiture pour toits inclinés) et Alwitra (systèmes détanchéité hautes performances pour les toits plats). Il dispose de 13 usines en France, Allemagne, Pologne, Espagne, Russie, États-Unis, Malaisie, Brésil et Turquie. Il réalise un chiffre daffaires consolidé de 350 M€ dans plus de 100 pays et emploie 2000 personnes de 34 nationalités différentes.
Since 1902, BIA is recognized by its customers for the quality of its products and services in the mining and quarrying, construction, transport and energy sectors as exclusive distributor of Komatsu equipment and parts, as well as other reputable manufacturers like Metso, Cummins, Bomag, MAN, Foton, Furukawa, GHH… for complementary products. Today BIA Group has become a well-established, multinational and trusted long-term business partner, operating in more than 20 countries in Africa and in the Benelux regions. The family-owned group distinguishes itself through the extent of its network and state-of-the-art technical facilities to support its clients close to their operations. The group is continuously developing its capabilities and expertise to meet the ever-growing customer needs. BIA provides a wide range of solutions including equipment sales, rental, parts supply, aftersales services as well as support services such as structured financing solutions, supply chain management and training to assist its customers on their projects development. More recently, BIA was pioneer in adopting innovation & technology solutions to increase customers productivity and safety on sites.
For over 40 years, Merit Kitchens has been providing homeowners, designers, and builders with fine cabinetry at an extraordinary value. All of our products are crafted from only the best raw materials and European hardware. Combining sturdy, traditional cabinetry construction with modern storage innovations, we manufacture and assemble our products in our state-of-the-art facility, pairing the precision of machines with the delicate touch of hand-finishing. Inspired both by traditional design and todays trends, Merit Kitchens prides itself on offering stylistic diversity, manufacturing excellence, environmentally-friendly choices, and shipping that is complete and on-time, all the time.
GF Casting Solutions is a technologically pioneering development partner and manufacturer of cast and additive components for the global automotive industry, aerospace and energy markets as well as for off-highway vehicles. The highly complex lightweight components are manufactured in one of four manufacturing technologies (iron sandcasting; aluminum & magnesium die-casting; precision casting; additive manufacturing) and machined up to a ready-to-mount level. In close cooperation with our customers and partners, we develop the casting innovations of the future - from the initial concept to precise implementation and reliable validation. As one of four strong divisions of Georg Fischer AG, GF Casting Solutions plays a leading role in the development and series production of casting solutions and connects more than 3700 employees at 14 sites worldwide. Visit us on www.gfcs.com Imprint: GF Casting Solutions AG Amsler-Laffon-Strasse 9 8201 Schaffhausen Switzerland Legal form: Stock Corporation Represented by: Carlos Vasto, President GF Casting Solutions, Member of the Group Management Trade register of canton of Schaffhausen, No. CH-290.3.002.299-3 Value-added tax No. 290.019
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.